We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.45B
AUM Growth
+$268M
Cap. Flow
+$5.47M
Cap. Flow %
0.1%
Top 10 Hldgs %
35.74%
Holding
946
New
25
Increased
88
Reduced
168
Closed
176

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$21.1M
2
CELG
Celgene Corp
CELG
+$8.69M
3
BKNG icon
Booking.com
BKNG
+$7.22M
4
ADBE icon
Adobe
ADBE
+$3.62M
5
STMP
Stamps.com, Inc.
STMP
+$3.54M

Top Sells

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$8.34M
2
RTX icon
RTX Corp
RTX
+$7.02M
3
MA icon
Mastercard
MA
+$4.51M
4
GILD icon
Gilead Sciences
GILD
+$4.33M
5
UNFI icon
United Natural Foods
UNFI
+$4.12M

Sector Composition

Rank Sector Weight
1 Technology 25.73%
2 Healthcare 17.8%
3 Consumer Staples 10.65%
4 Financials 9.43%
5 Consumer Discretionary 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRN
426
Amarin Corp
AMRN
$297M
$53K ﹤0.01%
666
TROW icon
427
T. Rowe Price
TROW
$23.8B
$52K ﹤0.01%
500
WPX
428
DELISTED
WPX Energy, Inc.
WPX
$52K ﹤0.01%
3,666
BWA icon
429
BorgWarner
BWA
$14B
$51K ﹤0.01%
1,136
GSK icon
430
GSK
GSK
$101B
$51K ﹤0.01%
1,160
VOT icon
431
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20B
$51K ﹤0.01%
+400
New +$50.2K
AYX
432
DELISTED
Alteryx Inc
AYX
$51K ﹤0.01%
2,000
ORBC
433
DELISTED
ORBCOMM, Inc.
ORBC
$51K ﹤0.01%
5,000
LW icon
434
Lamb Weston
LW
$7.3B
$50K ﹤0.01%
893
SRCL
435
DELISTED
Stericycle Inc
SRCL
$50K ﹤0.01%
740
-322
-30% -$21.9K
CGNX icon
436
Cognex
CGNX
$10.2B
$49K ﹤0.01%
800
FMS icon
437
Fresenius Medical Care
FMS
$12.6B
$49K ﹤0.01%
926
ITUB icon
438
Itaú Unibanco
ITUB
$81.6B
$49K ﹤0.01%
7,797
BC icon
439
Brunswick
BC
$5.21B
$48K ﹤0.01%
870
UTG icon
440
Reaves Utility Income Fund
UTG
$3.68B
$48K ﹤0.01%
1,555
XYL icon
441
Xylem
XYL
$28.5B
$48K ﹤0.01%
697
BKR icon
442
Baker Hughes
BKR
$63.8B
$47K ﹤0.01%
1,500
AMLP icon
443
Alerian MLP ETF
AMLP
$13.2B
$46K ﹤0.01%
+860
New +$46K
IRBT
444
DELISTED
iRobot
IRBT
$46K ﹤0.01%
600
VO icon
445
Vanguard Morningstar Mid-Cap ETF
VO
$110B
$46K ﹤0.01%
1,200
+800
+200% +$30.2K
HII icon
446
Huntington Ingalls Industries
HII
$12.9B
$45K ﹤0.01%
190
PGX icon
447
Invesco Preferred ETF
PGX
$3.76B
$45K ﹤0.01%
+3,000
New +$44.9K
A icon
448
Agilent Technologies
A
$41.9B
$44K ﹤0.01%
664
+150
+29% +$10.1K
MMSI icon
449
Merit Medical Systems
MMSI
$5.45B
$44K ﹤0.01%
1,010
-490
-33% -$20.6K
PETS icon
450
PetMed Express
PETS
$43M
$44K ﹤0.01%
975

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Loring Wolcott & Coolidge Fiduciary Advisors held 946 positions worth $5.45B, up 5.2% from $5.18B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2017 filing shows 25 new, 88 increased, 168 reduced and 176 closed positions. Its largest new stake was Veeva Systems: 6,655 shares worth $368K. The largest sale was Warner Bros, an estimated $8.34M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2017 buy was Veeva Systems: 6,655 shares worth $368K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Analog Devices in Q4 2017, an estimated $21.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2017 reduction was Warner Bros, cutting an estimated $8.34M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $441K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 36% of its $5.45B portfolio in Q4 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 25 new positions and closed 176 in Q4 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.45B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.